Author
E. Perez-Guijarro
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 44 mutual co-author links5 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Transitory Schwann Cell Precursor and hybrid states underpin melanoma therapy resistance and metastasis
V. Gopalan, C. W. Wong, R. Leshem…·K. L. Marie
This paper identifies transitory Schwann Cell Precursor and hybrid states in melanoma that correlate with therapy resistance and metastasis, and shows targeting Hdac2 can sensitize tumors to treatment.
DOI 10.1101/2022.10.14.512297 - Cancer BiologybioRxivPreprint
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
M. Pagadala, V. H. Wu, E. Perez-Guijarro…·H. Carter
The paper identifies germline variants associated with the tumor immune microenvironment, linking them to cancer risk and immunotherapy response.
DOI 10.1101/2021.04.14.436660 - Cancer BiologybioRxivPreprint
Multi-model preclinical platform predicts clinical response of melanoma to immunotherapy
E. Perez-Guijarro, H. H. Yang, R. E. Araya…·G. Merlino
The paper develops a preclinical platform using syngeneic mouse models to predict melanoma patient response to immunotherapy and identifies a melanocytic plasticity signature linked to treatment outcomes.
DOI 10.1101/727826 - Cancer BiologybioRxiv
Melanoblast transcriptome analysis reveals novel pathways promoting melanoma metastasis
K. L. Marie, A. Sassano, H. H. Yang…·P. J. Mishra
The paper analyzes the melanoblast transcriptome to identify genes involved in melanoma metastasis and discovers a 43-gene signature predictive of patient survival.
DOI 10.1038/s41467-019-14085-2